Ensign Peak Advisors, Inc Adicet Bio, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$13.43 - $18.74 $147,327 - $205,577
10,970 Added 11.15%
109,389 $1.56 Million
Q2 2022

Aug 12, 2022
BUY
$10.26 - $20.81 $770,300 - $1.56 Million
75,078 Added 321.66%
98,419 $1.44 Million
Q1 2022

May 16, 2022
BUY
$11.53 - $19.97 $269,121 - $466,119
23,341 New
23,341 $466,000

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $36M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email